AC Immune SA Free Cash Flow (FCF) History (ACIU)

AC Immune SA reported −CHF70.2M in free cash flow for fiscal 2025, a decrease of CHF135.4M from the previous fiscal year, with a free cash flow margin of −1963.67%.

View full AC Immune SA company overview

AC Immune SA free cash flow by year

AC Immune SA annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−CHF70.2M−CHF135.4M−1963.67%
20242024-12-31CHF65.3MCHF126.5M+238.99%
20232023-12-31−CHF61.2MCHF13.6M−413.55%
20222022-12-31−CHF74.8M−CHF6.5M−1901.07%
20212021-12-31−CHF68.3M−CHF7.1M
20202020-12-31−CHF61.2M−CHF114.6M−396.75%
20192019-12-31CHF53.3MCHF99.3M+48.29%
20182018-12-31−CHF45.9M−CHF22.0M−664.58%
20172017-12-31−CHF23.9M−CHF17.4M−117.98%
20162016-12-31−CHF6.5M−CHF50.4M−28.19%
20152015-12-31CHF43.8M+112.15%

AC Immune SA free cash flow growth trends

Over the last five reported fiscal years, free cash flow declined from −CHF61.2M to −CHF70.2M, a net decrease of CHF8.9M. AC Immune SA's latest reported quarter, Q3 2022, generated −CHF13.7M in free cash flow.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review AC Immune SA filings at SEC.gov ↗